二、对于《关于<公司非经营性资金占用及其他关联资金往来情况的专项报 告>的议案》的独立意见 经核查，我们一致认为：2023 年 1-6 月期间，公司与控股股东及其他关联方 的资金往来能够严格遵守《上市公司监管指引第 8 号——上市公司资金往来、对 外担保的监管要求》及《公司章程》等的相关规定，公司与公司股东及其他关联 方之间不存在非经营性资金往来，不存在控股股东及其关联方违规占用公司资金 的情形，没有损害公司和全体股东的利益。 湖南丽臣实业股份有限公司独立董事关于第五届董事会第十二次会议相关事项的独立意见 湖南丽臣实业股份有限公司独立董事 关于第五届董事会第十二次会议相关事项的独立意见 根据《中华人民共和国公司法》（以下称"《公司法》"）、《湖南丽臣实 业股份有限公司章程》（以下称"《公司章程》"）、《湖南丽臣实业股份有限 公司独立董事工作制度》等有关规定，我们作为湖南丽臣实业股份有限公司（以 下称"公司"）的独立董事，本着勤勉尽责的态度，客观公正的原则，现就公司 第五届董事会第十二次会议的相关事项，基于独立判断发表如下独立意见： 一、对于《关于<公司 2023 年半年度募集资金存放与使用情况专项报告>的 议 ...

根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司监管指 引第 2 号—上市公司募集资金管理和使用的监管要求（2022 年修订）》《上市公 司监管指引第 8 号—上市公司资金往来、对外担保的监管要求》等法律、法规和 规范性文件以及《湖南丽臣实业股份有限公司章程》（以下简称"《公司章程》"） 的规定，我们作为公司的监事，对公司第五届监事会第十一次会议审议的《公司 2023 年半年度募集资金存放与使用情况专项报告》《公司非经营性资金占用及其 他关联资金往来情况的专项报告》及《关于公司会计政策变更的议案》相关事项 发表核查意见如下： 湖南丽臣实业股份有限公司监事会 关于第五届监事会第十一次会议相关事项的核查意见 1、公司募集资金的管理、使用及运作程序符合《上市公司监管指引第 2 号 —上市公司募集资金管理和使用的监管要求（2022 年修订）》及《深圳证券交易 所上市公司自律监管指引第 1 号—主板上市公司规范运作》等有关规则和《湖南 丽臣实业股份有限公司募集资金管理办法》的规定，募集资金的实际使用合法、 合规，未发现违反法律、法规及损害股东利益的行为。 2、2023 年上半年度，公司不存在控股股东及 ...

证券代码：001218 证券简称：丽臣实业 公告编号：2023-069 湖南丽臣实业股份有限公司 关于公司会计政策变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示：本次会计政策变更是公司根据财政部发布的相关规定和要求进行的，变更 后会计政策能够客观、公允地反映公司的财务状况和经营成果，符合相关法律法规规定和 公司实际情况。本次会计政策变更不会对公司财务状况、经营成果和现金流量产生重大影 响，亦不存在损害公司及股东利益的情况。 湖南丽臣实业股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召 开第五届董事会第十二次会议、第五届监事会第十一次会议，会议审议通过了 《关于公司会计政策变更的议案》，具体情况如下： 一、本次会计政策变更情况概述 （一）会计政策变更原因 财政部于 2022 年 11 月 30 日颁布了《关于印发<企业会计准则解释第 16 号>的通知》（财会【2022】31 号）（以下简称"准则解释第 16 号"），规 定："关于单项交易产生的资产和负债相关的递延所得税不适用初始确认豁免 的会计处理"的内容，公司根据财政 ...

证券代码：001218 证券简称：丽臣实业 公告编号：2023-063 湖南丽臣实业股份有限公司 第五届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 湖南丽臣实业股份有限公司（以下简称"公司"）第五届董事会第十二次会 议于 2023 年 8 月 28 日在公司办公大楼五楼中心会议室以现场结合通讯方式召 开。会议通知已于 2023 年 8 月 22 日上午以电子邮件的方式送达各位董事。 会议由公司董事长刘茂林先生主持，本次董事会应出席会议的董事 9 人，实 际出席董事 9 人，董事会秘书、部分监事和高级管理人员列席了本次董事会会 议。会议召开的程序符合《中华人民共和国公司法》和《湖南丽臣实业股份有限 公司章程》的有关规定。 二、董事会会议审议情况 （一）审议通过了《关于<公司 2023 年半年度报告及其摘要>的议案》 经审议，董事会认为：《公司 2023 年半年度报告》及《公司 2023 年半年度 报告摘要》的编制程序符合法律、行政法规和中国证券监督管理委员会、深圳证 券交易所的相关法律法规、规范性文件的规定 ...

证券代码：001218 证券简称：丽臣实业 公告编号：2023-068 湖南丽臣实业股份有限公司 非经营性资金占用及其他关联资金往来情况汇总表 单位：万元 非经营性资金占用 资金占用方名称 占用方与上市公 司的关联关系 上市公司核算 的会计科目 2023 年期 初占用资 金余额 2023 年半年度占 用累计发生金额 （不含利息） 2023 年半年 度占用资金的 利息(如有) 2023 年半年 度偿还累计 发生金额 2023 年半年 度期末占用 资金余额 占用 形成 原因 占用性质 控股股东、实际控制人及 其附属企业 小计 - - - - - - - - - - 前控股股东、实际控制人 及其附属企业 小计 - - - - - - - - - - 其他关联方及附属企业 - 小计 - - - - - - - - - - 总计 - - - - - - - - - - 其他关联资金往来 资金往来方名称 往来方与上市公 司的关联关系 上市公司核算 的会计科目 2023 年期 初占用资 金余额 2023 年半年度占 用累计发生金额 (不含利息) 2023 年半年 度占用资金的 利息(如有) 2023 年半年 度偿还累计 发 ...

证券代码：001218 证券简称：丽臣实业 公告编号：2023-067 湖南丽臣实业股份有限公司 2023 年半年度募集资金存放与使用情况专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 根据《上市公司监管指引第 2 号—上市公司募集资金管理和使用的监管要 求》和《深圳证券交易所上市公司自律监管指引第 1 号—主板上市公司规范运 作》及相关格式指引的规定，湖南丽臣实业股份有限公司（以下简称"公司"） 现将 2023 年半年度募集资金存放与使用情况专项说明如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于核准湖南丽臣实业股份有限公司首次公开 发行股票的批复》（证监许可[2021]2977 号）核准，公司首次公开发行人民币普 通股（A 股）股票 2,250 万股，每股面值 1.00 元，每股发行价 45.51 元，共募集 资金人民币 102,397.50 万元，扣除保荐承销费用等发行费用（不含增值税）影响 后的募集资金净额为人民币 93,669.99 万元，其中：新增注册资本人民币 2,250 万 元，资本公 ...

编号： 2023-005 | --- | --- | |-----------------------|------------| | 特定对象调研 | 分析师会议 | | □媒体采访 | 业绩说明会 | | □新闻发布会 □路演活动 | | 投资者关系活 动类别 □现场参观 □其他 （ ） 海通证券 张翠翠女士 参与单位名称 及人员姓名 海通证券 邵锦女士 鹏华基金 王曦炜女士 时间 2023年6月19日15:00-16:00 地点 湖南丽臣实业股份有限公司办公大楼五楼会议室 形式 线上会议 董事会秘书、财务总监 郑钢先生 上市公司接待 人员姓名 证券事务代表 刘曾辉先生 双方就公司未来三年规划、经营等相关问题进行了沟通，相关问题记录如 下： 1、公司主营业务概述： 公司立足于精细化工领域，主营业务为表面活性剂和洗涤用品的研 投资者关系活 动主要内容介 绍 发、生产及销售。表面活性剂业务是公司主要的收入和利润来源，公司拥 有长沙、上海、东莞三大生产基地，表面活性剂年产能四十多万吨，表面 活性剂主导产品 2022 年行业排名位列全国前二。 2、目前下游需求的情况？ 2023年主要原料脂肪醇价格一季度处于震荡整 ...

编号： 2023-004 □特定对象调研 □分析师会议 □媒体采访 业绩说明会 □新闻发布会 □路演活动 投资者关系活 动类别 □现场参观 □其他 （ ） 参与单位名称 及人员姓名 广大投资者 时间 2023年5月8日15:00-16:30 地点 深交所互动易"云访谈"页面 公司董事、总经理 刘茂林先生 董事会秘书、财务总监 郑钢先生 上市公司接待 保荐代表人 陈进先生 人员姓名 独立董事 李力先生 财务部经理 周庄女士 证券事务代表 刘曾辉先生 1、2021 年主要表面活性剂产品产销量国内排名行业前三，2022 年公司排 名是否有所提升？ 投资者关系活 2022 年公司主要表面活性剂产品产销量国内排名行业前二。 动主要内容介 2、在洗涤用品领域公司具体有哪些品牌？ 绍 公司前身为湖南日用化工厂，洗涤用品包括自有品牌生产经营及 OEM 两种模式，其中自有品牌包括"马头"、"光辉"、"贝花"等，OEM 模式涉及 的主要品牌包括汰渍、白猫等。 | --- | |-------------------------------------------------------------------| | 3、表面活性 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥719,828,585.52, representing an increase of 11.85% compared to ¥643,572,644.55 in the same period last year[5] - Net profit attributable to shareholders for Q1 2023 was ¥38,657,288.87, a growth of 27.50% from ¥30,318,401.11 in Q1 2022[5] - Basic and diluted earnings per share for Q1 2023 were both ¥0.31, up 29.17% from ¥0.24 in Q1 2022[5] - Total operating revenue for the current period reached ¥719,828,585.52, an increase of 11.87% compared to ¥643,572,644.55 in the previous period[17] - Net profit for the current period was ¥38,657,288.87, representing a 27.55% increase from ¥30,318,401.11 in the previous period[19] - Earnings per share (basic and diluted) increased to ¥0.31 from ¥0.24, reflecting a growth of 29.17%[20] - The total profit for the current period was ¥40,389,936.05, up from ¥32,136,769.43 in the previous period, marking a growth of 25.67%[19] Cash Flow - The net cash flow from operating activities surged to ¥68,667,369.63, marking a significant increase of 993.94% compared to ¥6,277,086.52 in the previous year[5] - The net cash flow from financing activities was ¥898,924.94, a decline of 114.56% from a negative cash flow of ¥6,175,390.66 in Q1 2022[10] - Cash flow from operating activities generated a net amount of ¥68,667,369.63, significantly higher than ¥6,277,086.52 in the previous period[21] - The company experienced a net cash outflow from investing activities of ¥271,600,159.55, compared to a net outflow of ¥283,657,921.89 in the previous period[21] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥2,636,208,552.62, a decrease of 1.66% from ¥2,680,580,259.72 at the end of the previous year[5] - Cash and cash equivalents decreased from ¥923,820,144.81 to ¥720,657,665.61, a decline of approximately 22%[14] - Accounts receivable decreased from ¥401,760,171.47 to ¥337,390,745.81, a reduction of about 16%[14] - Inventory increased from ¥335,782,635.30 to ¥353,896,322.88, an increase of approximately 5.4%[14] - Total liabilities decreased from ¥618,830,462.13 to ¥535,806,541.98, a reduction of approximately 13.4%[16] - Total equity attributable to shareholders increased from ¥2,061,749,797.59 to ¥2,100,402,010.64, an increase of about 1.9%[16] Government Subsidies and Expenses - The company received government subsidies totaling ¥3,064,277.21 in Q1 2023, an increase of 168.99% compared to ¥1,139,172.29 in the same period last year[8] - The company reported a 77.39% decrease in prepaid expenses, which fell to ¥12,430,000.05 due to the arrival of raw materials for the Spring Festival[8] - Research and development expenses were ¥27,411,213.79, slightly up from ¥27,041,421.67 in the prior period[17] Shareholder Information - Total number of common shareholders at the end of the reporting period is 17,010[12] - The company has a total of 10 major shareholders, with the largest shareholder holding 17.33%[12] - The company reported no participation in margin financing and securities lending by the top 10 shareholders[13] Construction and Development - The company reported a 135.29% increase in construction in progress, amounting to ¥60,997,433.26, primarily due to expenditures related to the Shanghai Aowei 250,000-ton project[8] - The company has ongoing research and development efforts, although specific new products or technologies were not detailed in the report[15] Credit and Impairment - The company reported a credit impairment loss of ¥3,551,893.45, an increase from ¥1,970,210.91 in the previous period[19]

Financial Performance - The company's operating revenue for 2022 was CNY 3,044,480,042.42, representing a 10.77% increase compared to CNY 2,748,534,840.68 in 2021[20] - The net profit attributable to shareholders decreased by 32.94% to CNY 119,922,065.03 from CNY 178,831,396.77 in the previous year[20] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 105,869,484.98, down 35.80% from CNY 164,897,501.44 in 2021[20] - The net cash flow from operating activities increased by 42.69% to CNY 239,350,364.04, compared to CNY 167,741,260.39 in 2021[20] - Basic and diluted earnings per share were both CNY 0.95, a decrease of 45.71% from CNY 1.75 in the previous year[20] - The weighted average return on equity was 5.76%, down from 14.55% in 2021, reflecting an 8.79% decline[20] - Total assets at the end of 2022 were CNY 2,680,580,259.72, a 9.69% increase from CNY 2,443,821,927.10 at the end of 2021[20] - The net assets attributable to shareholders increased by 2.02% to CNY 2,061,749,797.59 from CNY 2,020,927,648.58 in 2021[20] Revenue Segmentation - The company’s surface active agent business generated revenue of ¥2,789,766,162.77, an increase of 11.61% year-on-year, with a gross profit margin of 11.47%, down 4.2 percentage points[56] - The washing products segment reported revenue of ¥191,513,444.34, a decline of 4.55% year-on-year, with a gross profit margin of 17.29%, down 1.48 percentage points[57] - Domestic sales reached ¥2,563,994,814.53, accounting for 84.22% of total revenue, with a slight increase of 0.58% year-on-year[60] - Export sales surged to ¥480,485,227.89, representing 15.78% of total revenue, marking a significant increase of 140.93% year-on-year[60] Production and Capacity - The company reported a total annual production of 4.262 million tons of surfactants in 2022, with a year-on-year increase of 3.55% in production volume[36] - The production capacity utilization rate for surfactants is 85.76%, with a designed capacity of 433,000 tons per year[43] - The company’s production capacity for anionic surfactants exceeds 400,000 tons annually, ranking among the top two in the industry in 2022[52] - The company is constructing a new production base for green surfactants in Shanghai with a planned capacity of 250,000 tons, aiming to enter trial production by the end of 2023[43] Market Position and Strategy - The market for surfactants in China is expected to grow at an annual rate exceeding 8%, driven by high demand in personal care and household cleaning sectors[35] - The company ranked among the top two in domestic production and sales of surfactants, capturing over 70% of the market share held by the top five manufacturers[36] - The company is focusing on sustainable development and green transformation in response to national policies promoting industrial upgrades[36] - The company is actively developing green surfactants and has launched amino acid-based surfactants into mass production[50] Research and Development - The company has a total of 24 patented technologies related to its core products, enhancing its R&D capabilities[42] - Research and development expenses increased by 18.24% to ¥111,758,311.44, driven by higher investment in R&D activities[76] - The number of R&D personnel rose to 106, a 6.00% increase from 2021, with R&D personnel now accounting for 15.54% of the total workforce[78] - The company is developing a new high-activity AOS powder production process, which aims to significantly reduce production energy consumption and costs[77] Environmental Compliance - The company has complied with all relevant environmental protection laws and regulations, establishing an environmental management system[190] - The company has obtained necessary environmental permits for its production facilities, including a wastewater discharge permit valid until June 22, 2027[191] - The company’s production bases have received environmental impact assessment approvals and have been granted discharge permits for their operations[192] - The company has successfully completed environmental evaluations for new projects, ensuring compliance with local regulations[191] Financial Management and Investments - The company reported a significant increase in cash and cash equivalents, with a net increase of ¥140,778,945.99, although this represents a 76.58% decrease compared to the previous year[81] - The total amount of raised funds is 936.70 million CNY, with 49.79 million CNY used during the reporting period, accounting for 40.97% of the total raised funds[103] - The company has committed to invest 385.84 million CNY in the Guangdong Licheng Aowei project, with 74.82% of the investment progress achieved by June 2022[105] - The company’s financial strategy includes a focus on risk management through derivative investments to protect shareholder interests[98] Shareholder Engagement and Governance - The company held its annual shareholders meeting with a participation rate of 74.99% on April 20, 2022, approving multiple key resolutions[138] - The company conducted a temporary shareholders meeting on June 23, 2022, with a participation rate of 74.92%, approving the election of new board members[139] - The company’s board members maintained a high attendance rate, with no member missing two consecutive meetings[157] - The company has a clear management structure for its investment development office, ensuring accountability and effective risk management[99] Employee Management and Development - The total number of employees at the end of the reporting period was 682, with 182 in the parent company and 500 in major subsidiaries[164] - The company emphasizes a performance-based compensation system, with variable pay linked to individual and company performance, including basic salary, performance pay, and annual bonuses[166] - The company has established a comprehensive training program to enhance employee skills and align their career development with the company's strategic goals[167] - The professional composition of employees includes 397 production personnel, 80 sales personnel, 106 technical personnel, 39 financial personnel, and 60 administrative personnel[164]